Quantal Bioscience
PrivateLast Round
Series B
Feb 9, 2026
Total Funding Raised
$130M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Quantal Bioscience is a biotechnology company that provides research and development services in applied microbiology and microbiomics across the health, medical, food, agricultural, and environmental sectors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Environmental Monitoring, Quality Management
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Quantal Bioscience Comparables
Compare Quantal Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eurofins Scientific SE | 75% | |
| Biomcare | 73% | |
| Metagen Australia | 66% |
Quantal Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 9, 2026 | ||||
| Series A | Aug 26, 2022 |
Quantal Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Creacion Ventures | Series A, Series B |
| OrbiMed | Series B, Series A |
| Sanofi Ventures | Series B |
| Lilly Asia Ventures | Series B |
| HongShan Capital Group (HSG) | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors increased 245% MoM, reaching 1K.
- Feb 9, 2026
$85M round led by Sanofi Ventures and Lilly Asia Ventures.
Quantal Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Quantal Bioscience's valuation, stock price, and market status.
Is Quantal Bioscience a public or private company?
Quantal Bioscience is a private company.
What is the current stock price of Quantal Bioscience?
Quantal Bioscience is a private company with no public stock price. Caplight tracks Quantal Bioscience's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Quantal Bioscience worth (valuation)?
Valuation information for Quantal Bioscience is not publicly available.
Can I buy Quantal Bioscience stock?
Quantal Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Quantal Bioscience's last funding round?
Quantal Bioscience's most recent funding round was Series B on February 9, 2026.
Who are the main investors in Quantal Bioscience?
Key investors in Quantal Bioscience include OrbiMed, Sanofi Ventures, Lilly Asia Ventures.
Will Quantal Bioscience IPO soon?
No public IPO plans have been announced for Quantal Bioscience.
How can I track Quantal Bioscience secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Quantal Bioscience's secondary market activity and sign up for updates.